Approval · Notice of Compliance 17362 · 2015
SIVEXTRO: Notice of Compliance 17362
Issued October 8, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17362
- Date
- October 8, 2015
- Company
- Merck Canada IncKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Merger - buyout
Products in this notice
Medicinal ingredients
- TEDIZOLID PHOSPHATE 200 MG per TAB
- TEDIZOLID PHOSPHATE 200 MG per VIAL